Literature DB >> 25110022

RBFOX2 protein domains and cellular activities.

Anurada D Arya1, David I Wilson1, Diana Baralle1, Michaela Raponi1.   

Abstract

RBFOX2 (RNA-binding protein, Fox-1 homologue 2)/RBM9 (RNA-binding-motif protein 9)/RTA (repressor of tamoxifen action)/HNRBP2 (hexaribonucleotide-binding protein 2) encodes an RNA-binding protein involved in tissue specific alternative splicing regulation and steroid receptors transcriptional activity. Its ability to regulate specific splicing profiles depending on context has been related to different expression levels of the RBFOX2 protein itself and that of other splicing regulatory proteins involved in the shared modulation of specific genes splicing. However, this cannot be the sole explanation as to why RBFOX2 plays a widespread role in numerous cellular mechanisms from development to cell survival dependent on cell/tissue type. RBFOX2 isoforms with altered protein domains exist. In the present article, we describe the main RBFOX2 protein domains, their importance in the context of splicing and transcriptional regulation and we propose that RBFOX2 isoform distribution may play a fundamental role in RBFOX2-specific cellular effects.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25110022     DOI: 10.1042/BST20140050

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  11 in total

1.  Morphological, genetic and clinical correlations in infantile hemangiomas and their mimics.

Authors:  Alina Costina Luca; Ingrith Crenguţa Miron; Laura Mihaela Trandafir; Elena Cojocaru; Ioana Alexandra Pădureţ; Mioara Florentina Trandafirescu; Alin Constantin Iordache; Elena Ţarcă
Journal:  Rom J Morphol Embryol       Date:  2020 Jul-Sep       Impact factor: 1.033

2.  Transforming Growth Factor-β-Induced RBFOX3 Inhibition Promotes Epithelial-Mesenchymal Transition of Lung Cancer Cells.

Authors:  Yong-Eun Kim; Jong Ok Kim; Ki-Sun Park; Minho Won; Kyoon Eon Kim; Kee K Kim
Journal:  Mol Cells       Date:  2016-07-19       Impact factor: 5.034

3.  Rbfox2 function in RNA metabolism is impaired in hypoplastic left heart syndrome patient hearts.

Authors:  Sunil K Verma; Vaibhav Deshmukh; Curtis A Nutter; Elizabeth Jaworski; Wenhao Jin; Lalita Wadhwa; Joshua Abata; Marco Ricci; Joy Lincoln; James F Martin; Gene W Yeo; Muge N Kuyumcu-Martinez
Journal:  Sci Rep       Date:  2016-08-03       Impact factor: 4.379

4.  RBFOX2 and alternative splicing in B-cell lymphoma.

Authors:  Hilmar Quentmeier; Claudia Pommerenke; Stephan H Bernhart; Wilhelm G Dirks; Vivien Hauer; Steve Hoffmann; Stefan Nagel; Reiner Siebert; Cord C Uphoff; Margarete Zaborski; Hans G Drexler
Journal:  Blood Cancer J       Date:  2018-08-10       Impact factor: 11.037

Review 5.  RBM22, a Key Player of Pre-mRNA Splicing and Gene Expression Regulation, Is Altered in Cancer.

Authors:  Benoît Soubise; Yan Jiang; Nathalie Douet-Guilbert; Marie-Bérengère Troadec
Journal:  Cancers (Basel)       Date:  2022-01-27       Impact factor: 6.639

6.  Prognostic alternative splicing signature in cervical squamous cell carcinoma.

Authors:  Hua-Yu Wu; Qi-Qi Li; Liang Liang; Lan-Lan Qiu; Hong-Wei Wei; Bing-Ying Huang; Chen Gang-; Rong-Quan He; Zhi-Guang Huang; Wei Hou; Qi-Ping Hu; Shang-Ling Pan
Journal:  IET Syst Biol       Date:  2020-12       Impact factor: 1.615

7.  Novel Rbfox2 isoforms associated with alternative exon usage in rat cortex and suprachiasmatic nucleus.

Authors:  L M M Partridge; D A Carter
Journal:  Sci Rep       Date:  2017-08-30       Impact factor: 4.379

8.  Stress Granules Contain Rbfox2 with Cell Cycle-related mRNAs.

Authors:  Chungoo Park; Sunkyung Choi; Yong-Eun Kim; Siyeo Lee; Su-Hyung Park; Robert S Adelstein; Sachiyo Kawamoto; Kee K Kim
Journal:  Sci Rep       Date:  2017-09-11       Impact factor: 4.379

Review 9.  Alternative mRNA Splicing in the Pathogenesis of Obesity.

Authors:  Chi-Ming Wong; Lu Xu; Mabel Yin-Chun Yau
Journal:  Int J Mol Sci       Date:  2018-02-23       Impact factor: 5.923

10.  Identification of putative biomarkers for Infantile Hemangiomas and Propranolol treatment via data integration.

Authors:  Horacio Gomez-Acevedo; Yuemeng Dai; Graham Strub; Carrie Shawber; June K Wu; Gresham T Richter
Journal:  Sci Rep       Date:  2020-02-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.